
NewLimit, a startup that aspires to reverse aging by manipulating cells, announced on Tuesday that it's raised $40 million in a Series A round from Kleiner Perkins and other venture firms, and from prominent individuals like former Google CEO Eric Schmidt and Y Combinator CEO Garry Tan.
The startup launched in late 2021 with the backing of Coinbase founder Brian Armstrong, who sold 2% of his holdings in the crypto company to invest an initial $110 million in the new venture alongside geneticist Blake Byers. The pair are two of four NewLimit cofounders.